Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03363568 · ClinicalTrials.gov registry record · NA
Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03363568 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 41 participants.
The verdict
NCT03363568, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study evaluates the impact of computerized inhibitory control training on attention-deficit hyperactivity disorder (ADHD) symptoms and ADHD-linked neural signatures in children with ADHD. Children were randomly assigned to adaptive computerized training (n=20) or non-adaptive computerized training control (n=20) with identical stimuli and goals.
Interventions
- BEHAVIORAL Adaptive Inhibitory Control Training
- BEHAVIORAL Non-adaptive Inhibitory Control Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-07-18 |
| Est. Completion | 2014-03-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03363568
The ClinicalTrials.gov registry entry for NCT03363568 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adaptive Inhibitory Control Training is the first listed.
NCT03363568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03363568 about?
NCT03363568 is a clinical study titled "Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)". This study evaluates the impact of computerized inhibitory control training on attention-deficit hyperactivity disorder (ADHD) symptoms and ADHD-linked neural signatures in children with ADHD. Children were randomly assigned to adaptive computerized training (n=20) or non-adaptive computerized train...
What is the current status of trial NCT03363568?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2013-07-18. Estimated completion is 2014-03-03.
What interventions are being tested in trial NCT03363568?
The interventions under investigation include: Adaptive Inhibitory Control Training (BEHAVIORAL), Non-adaptive Inhibitory Control Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03363568?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.